December 31, 2025, 11:05 AM UTC Patent lawsuits involving some of the pharmaceutical industrys most buzzworthy drugs and technologiesincluding the blockbuster weight-loss drug Wegovy and the delivery technology behind Covid-19 vaccinesare set to go to trial in 2026
Cognitive decline tracks with vascular health, metabolic health, neuroinflammation, and protein aggregation, and GLP-1 receptor agonists touch all four
Additionally, Williams feels proud of how her transparency has helped others not feel ashamed of doing what's best for their health, especially considering there's been a lot of controversy surrounding the use of GLP-1 medications
A -actin antibody (A5441, Sigma, 1:4000) was used as a loading control
Patients on GLP-1s for diabetes probably have better glycemic and metabolic control than those not on the treatments, he said, possibly delaying them from seeking further help and being diagnosed with dementia.